Skip to main content
. 2021 May 19;13(5):755. doi: 10.3390/pharmaceutics13050755

Figure 8.

Figure 8

Hemocompatibility of SF/PEG NPs ± 5-FU as revealed by the blood hemolysis assay after incubation with 12 mg/mL SF/PEG NPs ± 5-FU (**** p ≤ 0.0001).